Alcohol use disorder (AUD) is a common neuropsychiatric disorder that is a leading cause of morbidity and mortality worldwide; however, only a few pharmacological treatment options are currently available. While protein biomarkers with causal genetic evidence are promising novel drug target candidates for AUD, systematic scans of brain proteins have not been performed.